TOP ICE Trademark

Trademark Overview


On Wednesday, August 28, 2024, a trademark application was filed for TOP ICE with the United States Patent and Trademark Office. The USPTO has given the TOP ICE trademark a serial number of 98721275. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Saturday, April 5, 2025. This trademark is owned by Z-Star Therapeutics Inc.. The TOP ICE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Cell culture media for medical or veterinary purposes; Cells for medical or clinical use; Cells for medical use; Cellular function activating agents for medical purposes; Living cells for medical use

Biochemical research and analysis; Biotechnology research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of product design and development
top ice

General Information


Serial Number98721275
Word MarkTOP ICE
Filing DateWednesday, August 28, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateSaturday, April 5, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesBiological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Cell culture media for medical or veterinary purposes; Cells for medical or clinical use; Cells for medical use; Cellular function activating agents for medical purposes; Living cells for medical use
Goods and ServicesBiochemical research and analysis; Biotechnology research; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of product design and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZ-Star Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWoodbury, NY 11797

Trademark Events


Event DateEvent Description
Wednesday, August 28, 2024NEW APPLICATION ENTERED
Wednesday, August 28, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 4, 2025ASSIGNED TO EXAMINER
Wednesday, March 5, 2025NON-FINAL ACTION WRITTEN
Wednesday, March 5, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 5, 2025NON-FINAL ACTION E-MAILED
Thursday, March 6, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 6, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 6, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 28, 2025NON-FINAL ACTION WRITTEN
Friday, March 28, 2025NON-FINAL ACTION E-MAILED
Friday, March 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, April 5, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 5, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, April 5, 2025TEAS/EMAIL CORRESPONDENCE ENTERED